EVALUATING SAFETY AND EFFICACY OF TOL101 INDUCTION TO PREVENT KIDNEY TRANSPLANT REJECTION, PART A INTERIM ANALYSIS

被引：0

作者：

Getts, Daniel R. ^{[1
,2
]}

Wiseman, Alexander C. ^{[3
]}

Mulgaonkar, Shamkant ^{[4
]}

Sung, Randall S. ^{[5
]}

Melton, Larry B. ^{[6
]}

Waid, Thomas H. ^{[7
]}

Thompson, John S. ^{[7
]}

Brown, Stephen A. ^{[7
]}

Getts, Meghann T. ^{[1
]}

Frederick, Terra J. ^{[1
]}

Flechner, Stuart M. ^{[8
]}

机构：

[1] Tolera Therapeut, Res & Dev, Kalamazoo, MI USA

[2] Northwestern Univ, Dept Microbiol & Immunol, Chicago, IL 60611 USA

[3] Univ Colorado, Div Renal Dis & Hypertens, Transplant Ctr, Denver, CO 80202 USA

[4] St Barnabas Hosp, Dept Transplant, Livingston, NJ USA

[5] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA

[6] Baylor Univ Med Ctr, Dept Nephrol, Dallas, TX USA

[7] Univ Kentucky, Dept Internal Med, Lexington, KY 40506 USA

[8] Cleveland Clin, Dept Urol, Cleveland, OH 44106 USA

来源：

TRANSPLANT INTERNATIONAL | 2011年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：93 / 93

页数：1

共 50 条

[1] First in Man Evaluation of the Safety and Potential Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection
Flechner, S. M.
Mulgaonkar, S.
Melton, L.
Wiseman, A.
Sung, R.
Waid, T.
Shihab, F.
Agarwal, A.
Getts, Tegaue M.
Getts, D. R.
TRANSPLANTATION, 2012, 94 (10) : 102 - 102
[2] First-in-Human Study of the Safety and Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection
Flechner, S. M.
Mulgoankar, S.
Melton, L. B.
Waid, T. H.
Agarwal, A.
Miller, S. D.
Fokta, F.
Getts, M. T.
Frederick, T. J.
Herrman, J. J.
Puisis, J. P.
O'Toole, L.
Sung, R.
Shihab, F.
Wiseman, A. C.
Getts, D. R.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (06) : 1346 - 1355
[3] First in Man Evaluation of the Safety and Potential Efficacy of TOL101 Induction To Prevent Kidney Transplant Rejection.
Flechner, S. M.
Mulgaonkar, S.
Melton, L.
Wiseman, A.
Sung, R.
Waid, T.
Shihab, F.
Getts, M. T.
Getts, D. R.
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 55 - 55
[4] TOL101; a New Aid To Prevent Allograft Rejection.
Getts, Daniel R.
Brown, Stephen
Siemionow, Maria
Miller, Stephen D.
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 728 - 729
[5] Initial Phase 2 Safety, Efficacy, and Pharmacokinetic Study of TOL-101 for Induction Therapy in Kidney Transplantation.
Flechner, S.
Mulgoankar, S.
Melton, L.
Waid, T.
Agarwal, A.
Shihab, F.
Wiseman, A.
Getts, D.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 89 - 89
[6] Initial Phase 2 Safety, Efficacy, and Pharmacokinetic Study of TOL-101 for Induction Therapy in Kidney Transplantation.
Flechner, S.
Mulgoankar, S.
Melton, L.
Waid, T.
Agarwal, A.
Shihab, F.
Wiseman, A.
Getts, D.
TRANSPLANTATION, 2014, 98 : 89 - 89
[7] Evaluating Safety and Efficacy of Rabbit Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients
Khanmoradi, Kamran
Knorr, John P.
Feyssa, Eyob L.
Parsikia, Afshin
Jawa, Pankaj
Duy-Bao Dinh
Campos, Stalin
Zaki, Radi F.
Ortiz, Jorge A.
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2013, 11 (03) : 222 - 228
[8] Safety and efficacy of basiliximab for the prevention of acute rejection in kidney transplant recipients
Shah, MH
Bokhari, MZM
Bokhari, MTM
Farooq, A
Yousaf, SM
TRANSPLANTATION PROCEEDINGS, 2003, 35 (07) : 2737 - 2738
[9] Results of a Phase 2 Safety, Efficacy, and Pharmacokinetic Study of TOL-101, an Anti-TCR Monoclonal Antibody for the Prophylaxis of Acute Rejection in Kidney Transplantation
Flechner, S.
Mulgaonkar, S.
Melton, L.
Waid, T.
Sung, R.
Shihab, F.
Wiseman, A.
Getts, D.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 80 - 80
[10] Efficacy and Safety of Acute Antibody Rejection Treatment in Pediatric Kidney Transplant Recipients.
Kincaide, E.
Hitchman, K.
Hall, R.
Yamaguchi, I.
Crowther, B.
AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 715 - 715

← 1 2 3 4 5 →